搜索临床试验以:VEGFR1-1084、VEGFR2-169
总计893个结果
-
Japanese Foundation for Cancer ResearchHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Osaka UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo终止
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Groupe Hospitalier Pitie-Salpetriere完全的
-
Teikyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo终止
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo终止
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.主动,不招人
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo终止
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人粘膜相关淋巴组织结外边缘区B细胞淋巴瘤 | 淋巴结边缘区 B 细胞淋巴瘤 | 复发性成人伯基特淋巴瘤 | 复发性成人弥漫性大细胞淋巴瘤 | 复发性成人弥漫性混合细胞淋巴瘤 | 复发性成人弥漫性小裂细胞淋巴瘤 | 复发性成人免疫母细胞大细胞淋巴瘤 | 复发性成人淋巴母细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 脾边缘区淋巴瘤 | 华氏巨球蛋白血症 | 皮肤 B 细胞非霍奇金淋巴瘤 | 眼内淋巴瘤 | 移植后淋巴增生性疾病 | 复发性成人 III 级淋巴瘤样肉芽肿病 | 复发性小淋巴细胞淋巴瘤 | 小肠淋巴瘤 | 睾丸淋巴瘤 | 难治性毛细胞白血病 | 成人 III 级淋巴瘤样肉芽肿病美国
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences尚未招聘
-
Seattle Children's Hospital招聘中软组织肉瘤 | 癌 | 骨肉瘤 | 尤文肉瘤 | 横纹肌瘤 | 成神经细胞瘤 | 视网膜母细胞瘤 | 横纹肌肉瘤 | 肾母细胞瘤 | 肝母细胞瘤 | 滑膜肉瘤 | 促纤维增生性小圆细胞瘤 | 生殖细胞瘤 | 小儿实体瘤 | 透明细胞肉瘤 | 恶性周围神经鞘瘤美国
-
Vaximm GmbHPfizer; Merck KGaA, Darmstadt, Germany主动,不招人
-
Shahid Beheshti University of Medical Sciences完全的
-
NCIC Clinical Trials GroupGlaxoSmithKline完全的
-
AstraZeneca完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的复发性套细胞淋巴瘤 | 复发性成人急性淋巴细胞白血病 | 复发性小淋巴细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性慢性淋巴细胞白血病 | 复发性非霍奇金淋巴瘤 | 难治性非霍奇金淋巴瘤 | 难治性急性淋巴细胞白血病 | 难治性套细胞淋巴瘤 | 复发性慢性淋巴细胞白血病 | 难治性小淋巴细胞淋巴瘤 | 存在 CD19 阳性肿瘤细胞美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性套细胞淋巴瘤 | 转化的复发性非霍奇金淋巴瘤美国
-
Seattle Children's HospitalThe Evan Foundation; Ben Towne Center for Childhood Cancer Research主动,不招人